Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy
Clinical trial NCT04361253 · TERMINATED
Trial details
- NCT number
- NCT04361253
- Sponsor
- Brigham and Women's Hospital
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-30
- Primary completion
- 2021-04-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.